About Arigo biolaboratories
Arigo biolaboratories is a company based in Hsinchu (Taiwan) founded in 2014. It operates as a B2B and D2C. Arigo biolaboratories offers products and services including Primary Antibodies, Secondary Antibodies, ELISA Kits, Antibody Panels, and Recombinant Proteins. Arigo biolaboratories operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Hsinchu, Taiwan
- SectorsHealthcare
- Email••••••••
- Website arigobio.com
- Social X Facebook YouTube
- Legal Name Arigo
Products & Services of Arigo biolaboratories
Arigo biolaboratories offers a comprehensive portfolio of products and services, including Primary Antibodies, Secondary Antibodies, ELISA Kits, Antibody Panels, and Recombinant Proteins.
Antibodies for detecting specific proteins in experiments
Antibodies used to amplify signals in assays
Kits for quantitative detection of biomolecules
Panels for targeted analysis in various research areas
Proteins for use in experimental applications
Apps and channels of Arigo biolaboratories
its YouTube channel arigo biolaboratories has 784 subscribers and 22 videos.
Videos from Arigo biolaboratories
The most watched videos on Arigo biolaboratories's YouTube channel, arigo biolaboratories (784 subscribers). Click a video to play it here.
More on arigo biolaboratories.
Competitors of Arigo biolaboratories
Arigo biolaboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| itb-med.com | 2016 | Stockholm, Sweden | $87M | – | Monoclonal antibodies are developed to prevent transplant rejections. | |
| abrevbio.com | 2018 | Nanjing, China | $90M | – | Antibody-drug development platforms are provided for life sciences research. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| allelebiotech.com | 1999 | San Diego, United States | $18M | – | Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed. |
Detailed competitors of Arigo biolaboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Arigo biolaboratories
Websites that share an audience with Arigo biolaboratories (arigobio.com).
Websites whose visitors overlap most with Arigo biolaboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ibidi.com | 84% | 72.3K | #490,799 | View details | |
| nordicbiosite.com | 80% | 27.9K | #996,620 | View details | |
| biovendor.com | 77% | 21.2K | #1,380,534 | View details | |
| genscript.com | 64% | 456.1K | #94,888 | View details | |
| genetex.com | 62% | 48.7K | #686,186 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Arigo biolaboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Arigo biolaboratories
10 companies that operate in the same segment as Arigo biolaboratories (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Arigo biolaboratories
Arigo biolaboratories was founded in 2014.
Arigo biolaboratories is headquartered in Hsinchu, Taiwan.
Arigo Biolaboratories is a global supplier of high-quality research reagents, including antibodies, antibody duos, and ELISA kits. They focus on accelerating experiments in fields like immunology and cancer research through reliable products. Based in Taiwan, they serve researchers worldwide via direct sales and distributors, emphasizing quality and efficiency in biotechnology applications.
Arigo biolaboratories's top competitors include Sino Biological, GenScript and Y-Biologics.
Arigo biolaboratories offers Primary Antibodies, Secondary Antibodies, ELISA Kits, Antibody Panels, and Recombinant Proteins.
Arigo biolaboratories operates through Arigo.